Skip to main content
Clinical Trials/NCT04230928
NCT04230928
Completed
Not Applicable

A Pilot Study Comparing Dietary Approaches to Decrease Hypertension in a Lower Income, African American Population at Risk for Cardiovascular Disease

Baylor Research Institute1 site in 1 country64 target enrollmentMarch 5, 2020

Overview

Phase
Not Applicable
Intervention
Standard DPP-GLB diet
Conditions
Hypertension
Sponsor
Baylor Research Institute
Enrollment
64
Locations
1
Primary Endpoint
Changes in Systolic blood pressure
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

This study will test the preliminary efficacy of adding a very low carbohydrate dietary intervention to the evidence-based DPP-GLB on blood pressure reductions for lower-income AA men and women in a community-based clinic.

Detailed Description

This study will evaluate the effects of consuming a very low carbohydrate (VLC) diet in a sustainable community care setting, in addition to routine medical care, to African American (AA) with pre-hypertension, hypertension (stage 1-3), or cardiovascular disease risk factors. This study will also secondarily assess the feasibility of following a VLC diet in a low-income, AA population.

Registry
clinicaltrials.gov
Start Date
March 5, 2020
End Date
June 30, 2023
Last Updated
2 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 1\) men and women aged ≥ 18 years
  • 2\) willingness to participate in a 10-month study
  • 3\) systolic blood pressure \> 120 mm/Hg +/- diastolic blood pressure \> 80 mm/Hg
  • 4\) African American race

Exclusion Criteria

  • 1\) diagnosed congestive heart failure
  • 2\) Hypertension stage 4 or higher (e.g., SBP \>180 mm/Hg; DBP \> 110 mm/Hg)
  • 3\) received or needing more than 3 anti-hypertensive medications
  • 4\) pregnant or planning to become pregnant
  • 5\) receiving or needing a heart transplant
  • 6\) Using injected long or short-acting insulin for diabetes treatment
  • 7\) not African American race
  • 8\) unable to speak and read English with fluency

Arms & Interventions

Standard GLB Control

Individuals will receive the standard Diabetes Prevention Program-Group Lifestyle Balance (GLB) program as outlined by the American Diabetes Association. This program will be taught at the Baylor Scott \& White Health and Wellness Center by trained research staff.

Intervention: Standard DPP-GLB diet

Standard GLB Control

Individuals will receive the standard Diabetes Prevention Program-Group Lifestyle Balance (GLB) program as outlined by the American Diabetes Association. This program will be taught at the Baylor Scott \& White Health and Wellness Center by trained research staff.

Intervention: Standard DPP-GLB program modules

VLC-GLB Intervention

Individuals will receive a version of the DPP-GLB program in which 4 of the 12 modules will teach a very low carbohydrate diet instead of the standard. All other components of the DPP-GLB will follow the standard. This program will be taught at the Baylor Scott \& White Health and Wellness Center by trained research staff.

Intervention: Very low carbohydrate diet

VLC-GLB Intervention

Individuals will receive a version of the DPP-GLB program in which 4 of the 12 modules will teach a very low carbohydrate diet instead of the standard. All other components of the DPP-GLB will follow the standard. This program will be taught at the Baylor Scott \& White Health and Wellness Center by trained research staff.

Intervention: Standard DPP-GLB program modules

Outcomes

Primary Outcomes

Changes in Systolic blood pressure

Time Frame: Baseline; 12 weeks; 10 months

Measure changes in both systolic and diastolic blood pressure using digital sphygmomanometer; NOTE: Only Systolic BP is primary outcome, diastolic change will be a secondary outcome measure

Dietary changes in carbohydrate intake

Time Frame: Baseline; 12 weeks; 10 months

Assess changes in diet using ASA24 online dietary recall

Secondary Outcomes

  • Changes in Fasting blood glucose(Baseline; 12 weeks; 10 months)
  • Changes in Cholesterol and lipoproteins(Baseline; 12 weeks; 10 months)
  • Changes in Diastolic blood pressure(Baseline; 12 weeks; 10 months)
  • Changes in Body mass index (BMI)(Baseline; 12 weeks; 10 months)
  • Changes in Hemoglobin A1C(Baseline; 12 weeks; 10 months)
  • Dietary changes in caloric intake(Baseline; 12 weeks; 10 months)
  • Changes in % Body weight(Baseline; 12 weeks; 10 months)
  • Dietary changes in fat intake(Baseline; 12 weeks; 10 months)

Study Sites (1)

Loading locations...

Similar Trials